Research Article
Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
Table 3
Degree of tumor inhibition.
| ||||||||||||||||||||||||||||||||
P < 0.05, P < 0.01, compared with control. △P < 0.05, compared with erlotinib. |
| ||||||||||||||||||||||||||||||||
P < 0.05, P < 0.01, compared with control. △P < 0.05, compared with erlotinib. |